Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001075880-13-000102
Filing Date
2013-10-31
Accepted
2013-10-30 18:51:30
Documents
4
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 CONVERTED BY EDGARWIZ aaform6kproforma.htm 6-K 7255
2 CONVERTED BY EDGARWIZ asxreleaseappointmentcosec.htm EX-99 8268
3 IMAGE asxreleaseappointmentcose002.gif GRAPHIC 82375
4 IMAGE asxreleaseappointmentcose004.gif GRAPHIC 82375
  Complete submission text file 0001075880-13-000102.txt   243863
Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077
Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 131180418
SIC: 2834 Pharmaceutical Preparations